Latest Security News

Page 5 of 1863
American Tungsten & Antimony has produced one antimony ingot assaying 99.8% from US-mined material, meeting the highest ASTM B237 grade and exceeding the Regulus II specification. The result comes as the company pursues US government funding and offtake arrangements, although no commitments have been secured and AT4 does not yet control the relevant assets.
Victor Sage
Victor Sage
13 Oct 2026
Macro Metals has secured approximately A$3.28 million through a placement and the proposed conversion of its chairman’s loan, funding drilling across iron ore, copper and gold assets. The raise also completes the acquisition of Yandi South, but much of the capital remains tied to exploration outcomes that are yet to be established.
Maxwell Dee
Maxwell Dee
13 Oct 2026
Maronan Metals has secured firm commitments for a $20 million placement to expand drilling and bring forward engineering, permitting and metallurgical work at its Queensland project. The raise is conditional on shareholder approval, with Kinterra Capital set to lift its interest to 22.99%.
Maxwell Dee
Maxwell Dee
13 Oct 2026
PainChek has expanded its Sabra relationship from two initial facilities to 23 US communities across five operators, covering 808 contracted memory care licences. The immediate test is whether those contracts become implemented recurring revenue by the end of 2026.
Victor Sage
Victor Sage
13 Oct 2026
Arena REIT says Edge Early Learning has agreed or signed term sheets to sell a further 22 centre businesses, including all seven remaining Edge-operated centres at Arena properties. Rent continues to flow across the 27 affected properties, but operator changes still require due diligence, approvals and lease assignments.
Eva Park
Eva Park
13 Oct 2026
Cobre has outlined a three-stage plan to lift Sierra Atacama’s copper cathode capacity from its existing configuration to 18,000 tonnes per annum, then 25,000 tonnes, with a larger 50,000-tonne case under consideration. The targets depend on refurbishment, permitting, further drilling and resource modelling.
Maxwell Dee
Maxwell Dee
13 Oct 2026
Perpetual Resources and adviser GreenMet are assessing several US Government funding and financing pathways for the Nevada Scheelite tungsten project, as Washington prepares tighter defence sourcing rules. The interest is strategic, but no funding has been secured and the project remains without a Mineral Resource or Ore Reserve.
Maxwell Dee
Maxwell Dee
13 Oct 2026
Vection Technologies has secured a multi-year framework agreement with Italian telecommunications provider Retelit Digital Service, which has committed to generate at least approximately A$19.5 million in revenue for the company by June 2030. The deal expands Vection’s route into enterprise customers across Italy and Europe, although margins and payment terms remain undisclosed.
Sophie Babbage
Sophie Babbage
13 Oct 2026
Wildcat Resources ended September with A$76.1 million in cash after completing the first tranche of a A$60 million placement, giving it room to push Tabba Tabba towards its definitive feasibility study. Drilling also continued to expand Bolt Cutter Central ahead of a maiden resource targeted for Q4 2026.
Maxwell Dee
Maxwell Dee
13 Oct 2026
Venari Minerals has exercised its option to acquire a Nevada property and private water entitlement near its Red Mountain Lithium Project for total consideration of US$400,000. The deal addresses a stated development constraint, although completion and the project’s broader economics remain ahead.
Maxwell Dee
Maxwell Dee
13 Oct 2026
Cynata Therapeutics has lodged a replacement prospectus for a fully underwritten $913,000 entitlement offer, with the cash earmarked largely for adviser costs, intellectual property maintenance and working capital. The raising gives the biotech a near-term funding bridge, but the prospectus again flags a material uncertainty over its ability to continue as a going concern.
Victor Sage
Victor Sage
12 Oct 2026
Mesoblast has reported a sharp commercial step-up in FY2026, with Ryoncil generating US$115.2 million in net sales and total revenue reaching US$120.3 million. The company has also completed treatment in its 350-patient back-pain trial and refinanced its debt, but remains loss-making and expects to need more capital beyond the next 12 months.
Ada Torres
Ada Torres
12 Oct 2026

Browse the archive

Full archive